0001209191-14-070968.txt : 20141125
0001209191-14-070968.hdr.sgml : 20141125
20141125060214
ACCESSION NUMBER: 0001209191-14-070968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141124
FILED AS OF DATE: 20141125
DATE AS OF CHANGE: 20141125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Satter Muneer A
CENTRAL INDEX KEY: 0001315797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 141247724
MAIL ADDRESS:
STREET 1: C/O SATTER INVESTMENT MANAGEMENT, LLC
STREET 2: 676 NORTH MICHIGAN AVENUE, SUITE 4000
CITY: CHICAGO
STATE: IL
ZIP: 60611
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-24
0
0001517022
Akebia Therapeutics, Inc.
AKBA
0001315797
Satter Muneer A
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET, SUITE 1100
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2014-11-24
4
P
0
5000
13.88
A
1577560
I
See Footnote
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.74 to $13.99, inclusive. The reporting person undertakes to provide Akebia Therapeutics, Inc., any security holder of Akebia Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price range set forth in this footnote (1) to this Form 4.
The amount in Column 5 includes (a) 545,340 shares that are held by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 1,032,220 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (2), except to the extent of his pecuniary interest.
Robert M. Hayward, P.C., Attorney-in-Fact for Muneer A. Satter
2014-11-25